Phosphatidylinositol 3-Kinase-γ signaling promotes Campylobacter jejuni-induced colitis through neutrophil recruitment in mice

Journal of Immunology

Volumn 190, Issue 1, 2013, Pages 357-365

  Sun, Xiaolun ^a   Liu, Bo ^a,b   Sartor, Ryan Balfour ^a   Jobin, Christian ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 [5 (4 FLUORO 2 HYDROXYPHENYL)FURFURYLIDENE] 2,4 THIAZOLIDINEDIONE; BACTERIOCIN; CIPROFLOXACIN; GENTAMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10 RECEPTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; STREPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CAMPYLOBACTER JEJUNI INDUCED COLITIS; CAMPYLOBACTERIOSIS; COLITIS; COLON; COLONY FORMING UNIT; DISEASE SEVERITY; DRUG MECHANISM; ENTERITIS; ENZYME INHIBITION; INNATE IMMUNITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; CAMPYLOBACTER JEJUNI; CELLS, CULTURED; CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; COLITIS; INTERLEUKIN-10; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; SIGNAL TRANSDUCTION;

EID: 84871827193     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201825     Document Type: Article

References (35)

1. CDC 2012. Incidence of laboratory-confirmed bacterial and parasitic infections, and postdiarrheal hemolytic uremic syndrome (HUS), by year and pathogen, Foodborne Diseases Active Surveillance Network (FoodNet), United States, 1996-2011. http://www.cdc.gov/foodnet/data/trends/tables/table2a-b. html#table-2b. Accessed on September 5, 2012.
2. Blaser, M. J. 1997. Epidemiologic and clinical features of Campylobacter jejuni infections. J. Infect. Dis. 176(Suppl. 2): S103-S105. (Pubitemid 27505870)
3. Nachamkin, I. 2002. Chronic effects of Campylobacter infection. Microbes Infect. 4: 399-403. (Pubitemid 34270676)
4. Mortensen, N. P., M. L. Kuijf, C. W. Ang, P. Schiellerup, K. A. Krogfelt, B. C. Jacobs, A. van Belkum, H. P. Endtz, and M. P. Bergman. 2009. Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastroenteritis and reactive arthritis. Microbes Infect. 11: 988-994.
5. Gradel, K. O., H. L. Nielsen, H. C. Schønheyder, T. Ejlertsen, B. Kristensen, and H. Nielsen. 2009. Increased short- and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gastroenterology 137: 495-501.
6. Qin, H. Y., J. C. Wu, X. D. Tong, J. J. Sung, H. X. Xu, and Z. X. Bian. 2010. Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome. J. Gastroenterol. 46: 164-174. DOI: 10.1007/s00535-00010-00321-00536.
7. van den Bruele, T., P. E. Mourad-Baars, E. C. Claas, R. N. van der Plas, E. J. Kuijper, and R. G. Bredius. 2010. Campylobacter jejuni bacteremia and Helicobacter pylori in a patient with X-linked agammaglobulinemia. Eur. J. Clin. Microbiol. Infect. Dis. 29: 1315-1319.
8. Valenza, G., M. Frosch, and M. Abele-Horn. 2010. Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008. Scand. J. Infect. Dis. 42: 57-60.
9. Young, K. T., L. M. Davis, and V. J. Dirita. 2007. Campylobacter jejuni: molecular biology and pathogenesis. Nat. Rev. Microbiol. 5: 665-679. (Pubitemid 47278861)
10. Fouts, D. E., E. F. Mongodin, R. E. Mandrell, W. G. Miller, D. A. Rasko, J. Ravel, L. M. Brinkac, R. T. DeBoy, C. T. Parker, S. C. Daugherty, et al. 2005. Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. PLoS Biol. 3: e15.
11. Hofreuter, D., J. Tsai, R. O. Watson, V. Novik, B. Altman, M. Benitez, C. Clark, C. Perbost, T. Jarvie, L. Du, and J. E. Galán. 2006. Unique features of a highly pathogenic Campylobacter jejuni strain. Infect. Immun. 74: 4694-4707. (Pubitemid 44157257)
12. Lippert, E., T. Karrasch, X. Sun, B. Allard, H. H. Herfarth, D. Threadgill, and C. Jobin. 2009. Gnotobiotic IL-10;NF-κB mice develop rapid and severe colitis following Campylobacter jejuni infection. PLoS One 4: e7413.
13. Sun, X., D. Threadgill, and C. Jobin. 2012. Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling. Gastroenterology 142: 86-95.e5.
14. -/- mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype. Microb. Pathog. 45: 241-257.
15. Blaser, M. J., R. B. Parsons, and W. L. Wang. 1980. Acute colitis caused by Campylobacter fetus ss. jejuni. Gastroenterology 78: 448-453. (Pubitemid 10150482)
16. Rydström, A., and M. J. Wick. 2009. Monocyte and neutrophil recruitment during oral Salmonella infection is driven by MyD88-derived chemokines. Eur. J. Immunol. 39: 3019-3030.
17. Koyasu, S. 2003. The role of PI3K in immune cells. Nat. Immunol. 4: 313-319.
18. Günzl, P., and G. Schabbauer. 2008. Recent advances in the genetic analysis of PTEN and PI3K innate immune properties. Immunobiology 213: 759-765.
19. Li, Z., H. Jiang, W. Xie, Z. Zhang, A. V. Smrcka, and D. Wu. 2000. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science 287: 1046-1049. (Pubitemid 30094361)
20. Sasaki, T., J. Irie-Sasaki, R. G. Jones, A. J. Oliveira-dos-Santos, W. L. Stanford, B. Bolon, A. Wakeham, A. Itie, D. Bouchard, I. Kozieradzki, et al. 2000. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287: 1040-1046.
21. Ferguson, G. J., L. Milne, S. Kulkarni, T. Sasaki, S. Walker, S. Andrews, T. Crabbe, P. Finan, G. Jones, S. Jackson, et al. 2007. PI(3)Kγ has an important context-dependent role in neutrophil chemokinesis. Nat. Cell Biol. 9: 86-91. (Pubitemid 46024201)
22. Korlath, J. A., M. T. Osterholm, L. A. Judy, J. C. Forfang, and R. A. Robinson. 1985. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J. Infect. Dis. 152: 592-596. (Pubitemid 15018692)
23. Ribechini, E., P. J. M. Leenen, and M. B. Lutz. 2009. Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells. Eur. J. Immunol. 39: 3538-3551.
24. Bai, F., T. Town, F. Qian, P. Wang, M. Kamanaka, T. M. Connolly, D. Gate, R. R. Montgomery, R. A. Flavell, and E. Fikrig. 2009. IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog. 5: e1000610.
25. -/- mice. J. Biol. Chem. 283: 14182-14189.
26. Boxio, R., C. Bossenmeyer-Pourié, N. Steinckwich, C. Dournon, and O. Nüsse. 2004. Mouse bone marrow contains large numbers of functionally competent neutrophils. J. Leukoc. Biol. 75: 604-611. (Pubitemid 38405651)
27. Kankaanpää, P., K. Pahajoki, V. Marjomäki, J. Heino, and D. White. 2006. BioImageXD: new open source free software for the processing, analysis and visualization of multidimensional microscopic images. Microscopy Today 14: 12-16.
28. Ong, E., X. P. Gao, D. Predescu, M. Broman, and A. B. Malik. 2005. Role of phosphatidylinositol 3-kinase-γ in mediating lung neutrophil sequestration and vascular injury induced by E. coli sepsis. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L1094-L1103. (Pubitemid 41681344)
29. Camps, M., T. Rückle, H. Ji, V. Ardissone, F. Rintelen, J. Shaw, C. Ferrandi, C. Chabert, C. Gillieron, B. Françon, et al. 2005. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. 11: 936-943. (Pubitemid 41294438)
30. Snijders, F., E. J. Kuijper, B. de Wever, L. van der Hoek, S. A. Danner, and J. Dankert. 1997. Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24: 1107-1113. (Pubitemid 27249009)
31. Oomes, P. G., B. C. Jacobs, M. P. Hazenberg, J. R. Bänffer, and F. G. van der Meché. 1995. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann. Neurol. 38: 170-175.
32. Brinkmann, V., U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D. S. Weiss, Y. Weinrauch, and A. Zychlinsky. 2004. Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535. (Pubitemid 38314426)
33. Chin, A. C., and C. A. Parkos. 2006. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking. Ann. N.Y. Acad. Sci. 1072: 276-287. (Pubitemid 44448460)
34. van Spreeuwel, J. P., G. C. Duursma, C. J. Meijer, R. Bax, P. C. Rosekrans, and J. Lindeman. 1985. Campylobacter colitis: histological immunohistochemical and ultrastructural findings. Gut 26: 945-951.
35. Ternhag, A., T. Asikainen, J. Giesecke, and K. Ekdahl. 2007. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin. Infect. Dis. 44: 696-700.